|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
352 a.a.
|
 |
|
|
|
|
|
|
|
164 a.a.
|
 |
|
|
|
|
|
|
|
164 a.a.
|
 |
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/isomerase/immunosuppressant
|
 |
|
Title:
|
 |
Crystal structure of human calcineurin complexed with cyclos and human cyclophilin
|
|
Structure:
|
 |
Calmodulin-dependent calcineurin a subunit, alpha chain: a. Fragment: truncated form (residues 20-392). Synonym: serine/threonine protein phosphatase 2b catalytic alpha isoform, cam-prp catalytic subunit. Engineered: yes. Calcineurin b subunit isoform 1. Chain: b. Synonym: protein phosphatase 2b regulatory subunit 1, prote
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Tolypocladium inflatum. Organism_taxid: 29910
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
3.10Å
|
R-factor:
|
0.250
|
R-free:
|
0.300
|
|
|
Authors:
|
 |
L.Jin,S.C.Harrison
|
Key ref:
|
 |
L.Jin
and
S.C.Harrison
(2002).
Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.
Proc Natl Acad Sci U S A,
99,
13522-13526.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Aug-02
|
Release date:
|
16-Oct-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q08209
(PP2BA_HUMAN) -
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform
|
|
|
|
Seq: Struc:
|
 |
 |
 |
521 a.a.
352 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P63098
(CANB1_HUMAN) -
Calcineurin subunit B type 1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
170 a.a.
164 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.3.1.3.16
- Phosphoprotein phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
A phosphoprotein + H2O = a protein + phosphate
|
 |
 |
 |
 |
 |
phosphoprotein
|
+
|
H(2)O
|
=
|
protein
|
+
|
phosphate
Bound ligand (Het Group name = )
corresponds exactly
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain C:
E.C.5.2.1.8
- Peptidylprolyl isomerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Peptidylproline (omega=180) = peptidylproline (omega=0)
|
 |
 |
 |
 |
 |
Peptidylproline (omega=180)
|
=
|
peptidylproline (omega=0)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
5 terms
|
 |
|
Biological process
|
viral reproduction
|
24 terms
|
 |
|
Biochemical function
|
hydrolase activity
|
11 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
99:13522-13526
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.
|
|
L.Jin,
S.C.Harrison.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Calcineurin (Cn), a Ca(2+)/calmodulin-dependent Ser/Thr protein phosphatase, is
an important participant in signaling pathways that activate T cells. It is the
target of the immunosuppressive drugs cyclosporin A (CsA) and FK506. These drugs
bind proteins known as cyclophilin (Cyp) and FK506-binding protein,
respectively, and the drug-protein complexes in turn inhibit Cn. We report the
crystal structure of a Cyp/CsA/Cn ternary complex, determined to a resolution of
3.1 A. Residues 3-9 of CsA, particularly N-methyl leucines 4 and 6, and Trp-121
of Cyp form a composite surface for interaction with Cn. The hydrophobic
interface buries two hydrogen bonds. The structure accounts clearly for the
effects of mutations in Cn on CsA-resistance and for the way modifications of
CsA alter immunosuppressive activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig 1. Ribbon diagrams of the Cyp/CsA/Cn ternary complex
(A), and the FKBP/FK506/Cn complex (B) (2, 3). CsA and FK506 are
shown in ball-and-stick representations; CnA is in yellow (with
the CnB-binding segment in dark yellow); CnB, red; Cyp, green;
FKBP, blue; and Ca^2+ ions, cyan balls. The Cn active-site cleft
is indicated with an asterisk.
|
 |
Figure 3.
Fig 3. Details of the interaction between CsA and Cn. CsA,
ball-and-stick; CnA, yellow; CnB, red; Cyp, green. Some Cn and
Cyp residues involved in CsA binding are represented as
ball-and-sticks. The backbone positions of other residues
mentioned in the text (CnA344Pro, CnA353Ser, CnB118Met,
CnB122Asn, Cyp103Ala) are shown as gray spheres. There are two
hydrophobic surfaces for CsA binding, one formed by residues
from CnA and CnB (upper right) and the other formed jointly by
CnA and Cyp (lower left). The two hydrogen bonds between CsA and
CnA are indicated as broken lines.
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Kuglstatter,
F.Mueller,
E.Kusznir,
B.Gsell,
M.Stihle,
R.Thoma,
J.Benz,
L.Aspeslet,
D.Freitag,
and
M.Hennig
(2011).
Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin).
|
| |
Acta Crystallogr D Biol Crystallogr, 67,
119-123.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Li,
A.Rao,
and
P.G.Hogan
(2011).
Interaction of calcineurin with substrates and targeting proteins.
|
| |
Trends Cell Biol, 21,
91.
|
 |
|
|
|
|
 |
P.D.Dearmond,
G.M.West,
H.T.Huang,
and
M.C.Fitzgerald
(2011).
Stable isotope labeling strategy for protein-ligand binding analysis in multi-component protein mixtures.
|
| |
J Am Soc Mass Spectrom, 22,
418-430.
|
 |
|
|
|
|
 |
S.R.Pereira,
V.T.Vasconcelos,
and
A.Antunes
(2011).
The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins.
|
| |
Crit Rev Toxicol, 41,
83.
|
 |
|
|
|
|
 |
A.Galat,
and
J.Bua
(2010).
Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.
|
| |
Cell Mol Life Sci, 67,
3467-3488.
|
 |
|
|
|
|
 |
Q.Chen,
W.Wu,
J.Li,
and
Q.Wei
(2010).
The polarity of the amino acid residue 118 of calcineurin B is closely linked to calcineurin enzyme activity.
|
| |
IUBMB Life, 62,
561-567.
|
 |
|
|
|
|
 |
S.Malouitre,
H.Dube,
D.Selwood,
and
M.Crompton
(2010).
Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation.
|
| |
Biochem J, 425,
137-148.
|
 |
|
|
|
|
 |
A.Rodríguez,
J.Roy,
S.Martínez-Martínez,
M.D.López-Maderuelo,
P.Niño-Moreno,
L.Ortí,
D.Pantoja-Uceda,
A.Pineda-Lucena,
M.S.Cyert,
and
J.M.Redondo
(2009).
A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.
|
| |
Mol Cell, 33,
616-626.
|
 |
|
|
|
|
 |
J.Brewin,
C.Mancao,
K.Straathof,
H.Karlsson,
S.Samarasinghe,
P.J.Amrolia,
and
M.Pule
(2009).
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.
|
| |
Blood, 114,
4792-4803.
|
 |
|
|
|
|
 |
J.O.Liu
(2009).
Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation.
|
| |
Immunol Rev, 228,
184-198.
|
 |
|
|
|
|
 |
M.Sieber,
and
R.Baumgrass
(2009).
Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
|
| |
Cell Commun Signal, 7,
25.
|
 |
|
|
|
|
 |
W.C.Van Voorhis,
W.G.Hol,
P.J.Myler,
and
L.J.Stewart
(2009).
The role of medical structural genomics in discovering new drugs for infectious diseases.
|
| |
PLoS Comput Biol, 5,
e1000530.
|
 |
|
|
|
|
 |
Y.Shi
(2009).
Serine/threonine phosphatases: mechanism through structure.
|
| |
Cell, 139,
468-484.
|
 |
|
|
|
|
 |
Y.Zhang,
F.Erdmann,
and
G.Fischer
(2009).
Augmented photoswitching modulates immune signaling.
|
| |
Nat Chem Biol, 5,
724-726.
|
 |
|
|
|
|
 |
B.Wang,
P.Zhang,
and
Q.Wei
(2008).
Recent progress on the structure of Ser/Thr protein phosphatases.
|
| |
Sci China C Life Sci, 51,
487-494.
|
 |
|
|
|
|
 |
Q.Ye,
H.Wang,
J.Zheng,
Q.Wei,
and
Z.Jia
(2008).
The complex structure of calmodulin bound to a calcineurin peptide.
|
| |
Proteins, 73,
19-27.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.G.Ptak,
P.A.Gallay,
D.Jochmans,
A.P.Halestrap,
U.T.Ruegg,
L.A.Pallansch,
M.D.Bobardt,
M.P.de Béthune,
J.Neyts,
E.De Clercq,
J.M.Dumont,
P.Scalfaro,
K.Besseghir,
R.M.Wenger,
and
B.Rosenwirth
(2008).
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
|
| |
Antimicrob Agents Chemother, 52,
1302-1317.
|
 |
|
|
|
|
 |
K.Takeuchi,
M.H.Roehrl,
Z.Y.Sun,
and
G.Wagner
(2007).
Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.
|
| |
Structure, 15,
587-597.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Sánchez-Barrena,
H.Fujii,
I.Angulo,
M.Martínez-Ripoll,
J.K.Zhu,
and
A.Albert
(2007).
The structure of the C-terminal domain of the protein kinase AtSOS2 bound to the calcium sensor AtSOS3.
|
| |
Mol Cell, 26,
427-435.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Sieber,
M.Karanik,
C.Brandt,
C.Blex,
M.Podtschaske,
F.Erdmann,
R.Rost,
E.Serfling,
J.Liebscher,
M.Pätzel,
A.Radbruch,
G.Fischer,
and
R.Baumgrass
(2007).
Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3.
|
| |
Eur J Immunol, 37,
2617-2626.
|
 |
|
|
|
|
 |
V.Venugopal,
B.Sen,
A.K.Datta,
and
R.Banerjee
(2007).
Structure of cyclophilin from Leishmania donovani at 1.97 A resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
60-64.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.J.Steinbach,
J.L.Reedy,
R.A.Cramer,
J.R.Perfect,
and
J.Heitman
(2007).
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
|
| |
Nat Rev Microbiol, 5,
418-430.
|
 |
|
|
|
|
 |
C.Marchand,
S.Antony,
K.W.Kohn,
M.Cushman,
A.Ioanoviciu,
B.L.Staker,
A.B.Burgin,
L.Stewart,
and
Y.Pommier
(2006).
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
|
| |
Mol Cancer Ther, 5,
287-295.
|
 |
|
|
|
|
 |
D.J.Loane,
G.A.Hicks,
B.A.Perrino,
and
N.V.Marrion
(2006).
Inhibition of BK channel activity by association with calcineurin in rat brain.
|
| |
Eur J Neurosci, 24,
433-441.
|
 |
|
|
|
|
 |
D.Y.Yu,
J.Luo,
F.Bu,
G.J.Song,
L.Q.Zhang,
and
Q.Wei
(2006).
Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice.
|
| |
Biol Chem, 387,
977-983.
|
 |
|
|
|
|
 |
N.Leulliot,
G.Vicentini,
J.Jordens,
S.Quevillon-Cheruel,
M.Schiltz,
D.Barford,
H.van Tilbeurgh,
and
J.Goris
(2006).
Crystal structure of the PP2A phosphatase activator: implications for its PP2A-specific PPIase activity.
|
| |
Mol Cell, 23,
413-424.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Adams,
A.Musiyenko,
R.Kumar,
and
S.Barik
(2005).
A novel class of dual-family immunophilins.
|
| |
J Biol Chem, 280,
24308-24314.
|
 |
|
|
|
|
 |
B.Chan,
G.Greenan,
F.McKeon,
and
T.Ellenberger
(2005).
Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
|
| |
Proc Natl Acad Sci U S A, 102,
13075-13080.
|
 |
|
|
|
|
 |
J.R.Blankenship,
and
J.Heitman
(2005).
Calcineurin is required for Candida albicans to survive calcium stress in serum.
|
| |
Infect Immun, 73,
5767-5774.
|
 |
|
|
|
|
 |
P.Wang,
and
J.Heitman
(2005).
The cyclophilins.
|
| |
Genome Biol, 6,
226.
|
 |
|
|
|
|
 |
Y.Pommier,
and
J.Cherfils
(2005).
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.
|
| |
Trends Pharmacol Sci, 26,
138-145.
|
 |
|
|
|
|
 |
R.Kumar,
A.Musiyenko,
A.Oldenburg,
B.Adams,
and
S.Barik
(2004).
Post-translational generation of constitutively active cores from larger phosphatases in the malaria parasite, Plasmodium falciparum: implications for proteomics.
|
| |
BMC Mol Biol, 5,
6.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |